Medical Vision Australia Holdings

Medical Vision Australia Holdings was an Australian healthcare company associated with the distribution of medical devices, particularly breast implants, in Australia. Public reporting links the broader Medical Vision Australia business to the Australian distribution of Poly Implant Prothèse (PIP) breast implants during the PIP implant controversy. Available public evidence suggests this was a commercial-stage medical device distribution business rather than a drug-development biotech company. ASIC published a proposed deregistration notice for Medical Vision Australia Holdings Pty Ltd, indicating the entity was no longer active. There is no clear evidence that it operated a therapeutic pipeline, platform technology, or clinical-stage pharmaceutical or biotech programs.